Influenza vaccine programs for children in low- and middle-income countries: current status and way forward

References

• World Health Organization. Ten threats to global health in 2019. (2019). Available from: https://www.who.int/emergencies/ten-threats-to-global-health-in-2019
   Google Scholar
• Payne AM. The influenza programme of WHO. Bull World Health Organ. 1953;8(5–6):755–774.
   PubMedGoogle Scholar
• GBD 2017 Influenza Collaborators. Mortality, morbidity, and hospitalisations due to influenza lower respiratory tract infections, 2017: an analysis for the global burden of disease study 2017. Lancet Respir Med. 2019;7(1):69–89.
   Web of Science ®Google Scholar
• Iuliano AD, Roguski KM, Chang HH, et al. Estimates of global seasonal influenza-associated respiratory mortality: a modelling study. Lancet. 2018;391(10127):1285–1300.
   PubMed Web of Science ®Google Scholar
• Nair H, Brooks WA, Katz M, et al. Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysis. Lancet. 2011;378(9807):1917–1930.
   PubMed Web of Science ®Google Scholar
• Ortiz JR, Perut M, Dumolard L, et al. A global review of national influenza immunization policies: analysis of the 2014 WHO/UNICEF Joint Reporting Form on immunization. Vaccine. 2016;34(45):5400–5405.
   PubMed Web of Science ®Google Scholar
• Palache A, Abelin A, Hollingsworth R, et al. Survey of distribution of seasonal influenza vaccine doses in 201 countries (2004-2015): the 2003 World Health Assembly resolution on seasonal influenza vaccination coverage and the 2009 influenza pandemic have had very little impact on improving influenza control and pandemic preparedness. Vaccine. 2017;35(36):4681–4686.
   PubMed Web of Science ®Google Scholar
• Lambach P, Alvarez AM, Hirve S, et al. Considerations of strategies to provide influenza vaccine year round. Vaccine. 2015;33(47):6493–6498.
   PubMed Web of Science ®Google Scholar
• Lambach P, Hombach J, Ortiz JR. A global perspective of maternal influenza immunization. Vaccine. 2015;33(47):6376–6379.
   PubMed Web of Science ®Google Scholar
• Paules CI, Marston HD, Eisinger RW, et al. The pathway to a universal influenza vaccine. Immunity. 2017;47(4):599–603.
   PubMed Web of Science ®Google Scholar
• Neuzil KM, Bresee JS, de la Hoz F, et al. Data and product needs for influenza immunization programs in low- and middle-income countries: rationale and main conclusions of the WHO preferred product characteristics for next-generation influenza vaccines. Vaccine. 2017;35(43):5734–5737.
   PubMed Web of Science ®Google Scholar
• Ortiz JR, Neuzil KM. Influenza immunization in low- and middle-income countries: preparing for next-generation influenza vaccines. J Infect Dis. 2019;219:S97–S106.
   PubMedGoogle Scholar
• World Health Organization. Vaccines against influenza WHO position paper - november 2012. Wkly Epidemiol Rec. 2012;87(47):461–476.
   PubMedGoogle Scholar
• Belshe RB. The origins of pandemic influenza–lessons from the 1918 virus. N Engl J Med. 2005;353(21):2209–2211.
   PubMed Web of Science ®Google Scholar
• Beigel JH, Farrar J, Han AM, et al. Avian influenza A (H5N1) infection in humans. N Engl J Med. 2005;353(13):1374–1385.
   PubMed Web of Science ®Google Scholar
• McCullers JA. Preparing for the next influenza pandemic. Pediatr Infect Dis J. 2008;27(10 Suppl):S57–59.
   PubMed Web of Science ®Google Scholar
• World Health Organization. A system for the prequalification of vaccines for UN supply. (2019). Available from: https://www.who.int/immunization_standards/vaccine_quality/pq_system/en/
   Google Scholar
• World Health Organization. WHO prequalified vaccines. (2019). Available from: https://extranet.who.int/gavi/PQ_Web/
   Google Scholar
• World Health Organization. Vaccine donations: WHO-UNICEF joint statement. (2010). Available from: https://www.who.int/immunization/hpv/plan/who_unicef_joint_statement_on_vaccine_donations_who_unicef_2011.pdf
   Google Scholar
• Steel J. A paradigm shift in vaccine production for pandemic influenza. Ann Transl Med. 2015;3(12):165.
   PubMed Web of Science ®Google Scholar
• Halsey NA, Talaat KR, Greenbaum A, et al. The safety of influenza vaccines in children: an Institute for Vaccine Safety white paper. Vaccine. 2015;33(Suppl 5):F1–F67.
   PubMedGoogle Scholar
• Hendriks J, Hutubessy RCW, Grohmann G, et al. Quadrivalent influenza vaccines in low and middle income countries: cost-effectiveness, affordability and availability. Vaccine. 2018;36(28):3993–3997.
   PubMed Web of Science ®Google Scholar
• Diallo A, Victor JC, Feser J, et al. Immunogenicity and safety of MF59-adjuvanted and full-dose unadjuvanted trivalent inactivated influenza vaccines among vaccine-naive children in a randomized clinical trial in rural Senegal. Vaccine. 2018;36(43):6424–6432.
   PubMed Web of Science ®Google Scholar
• Claeys C, Zaman K, Dbaibo G, et al. Prevention of vaccine-matched and mismatched influenza in children aged 6-35 months: a multinational randomised trial across five influenza seasons. Lancet Child Adolesc Health. 2018;2(5):338–349.
   PubMedGoogle Scholar
• Friede M, Palkonyay L, Alfonso C, et al. WHO initiative to increase global and equitable access to influenza vaccine in the event of a pandemic: supporting developing country production capacity through technology transfer. Vaccine. 2011;29:A2–A7.
   PubMed Web of Science ®Google Scholar
• Levine OS, Hajjeh R, Wecker J, et al. A policy framework for accelerating adoption of new vaccines. Hum Vaccin. 2010;6(12):1021–1024.
   PubMed Web of Science ®Google Scholar
• Kochhar S, Edwards KM, Ropero Alvarez AM, et al. Introduction of new vaccines for immunization in pregnancy – programmatic, regulatory, safety and ethical considerations. Vaccine. 2019;37(25):3267–3277.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Meeting of the strategic advisory group of experts on immunization, april 2015: conclusions and recommendations. Wkly Epidemiol Rec. 2015;90(22):261–278.
   PubMedGoogle Scholar
• World Health Organization. Summary of WHO position papers - recommended routine immunizations for children. (2018). Available from: https://www.who.int/immunization/policy/Immunization_routine_table2.pdf
   Google Scholar
• World Health Organization. 9 in 10 infants worldwide received vaccinations in 2017. (2019). Available from: https://www.who.int/immunization/newsroom/2018_infants_worldwide_vaccinations/en/
   Google Scholar
• World Health Organization. Pertussis vaccines: WHO position paper - september 2015. Wkly Epidemiol Rec. 2015;90(35):433–458.
   PubMedGoogle Scholar
• Sobanjo-Ter Meulen A, Duclos P, McIntyre P, et al. Assessing the evidence for maternal pertussis immunization: a report from the Bill & Melinda Gates foundation symposium on pertussis infant disease burden in low- and lower-middle-income countries. Clin Infect Dis. 2016;63(suppl4):S123–s133.
   PubMedGoogle Scholar
• World Health Organization. Maternal and Neonatal Tetanus Elimination (MNTE). (2019). Available from: https://www.who.int/immunization/diseases/MNTE_initiative/en/
   Google Scholar
• World Health Organization. Measles vaccines: WHO position paper. Wkly Epidemiol Rec. 2009;84(35):349–360.
   PubMedGoogle Scholar
• World Health Organization. WHO vaccine-preventable diseases: monitoring system. 2018 global summary. (2019). Available from: http://apps.who.int/immunization_monitoring/globalsummary/schedules
   Google Scholar
• Ford AQ, Touchette N, Fenton Hall B, et al. Meeting report: global vaccine and immunization research forum. Vaccine. 2018;36(7):915–920.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Global vaccine action plan 2011-2020. 2013.
   Google Scholar
• World Health Organization. SAGE april 2017 national immunization technical advisory groups background paper. (2017). Available from: https://www.who.int/immunization/sage/meetings/2017/april/1_NITAGs_background_document_SAGE_April_2017.pdf
   Google Scholar
• Ortiz JR, Sotomayor V, Uez OC, et al. Strategy to enhance influenza surveillance worldwide. Emerg Infect Dis. 2009;15(8):1271–1278.
   PubMed Web of Science ®Google Scholar
• Ortiz JR, Neuzil KM, Rue TC, et al. Population-based incidence estimates of influenza-associated respiratory failure hospitalizations, 2003 to 2009. Am J Respir Crit Care Med. 2013;188(6):710–715.
   PubMed Web of Science ®Google Scholar
• McMorrow ML, Tempia S, Walaza S, et al. Prioritization of risk groups for influenza vaccination in resource limited settings - A case study from South Africa. Vaccine. 2019;37(1):25–33.
   PubMed Web of Science ®Google Scholar
• Poehling KA, Edwards KM, Weinberg GA, et al. The underrecognized burden of influenza in young children. N Engl J Med. 2006;355(1):31–40.
   PubMed Web of Science ®Google Scholar
• Neuzil KM, Zhu Y, Griffin MR, et al. Burden of interpandemic influenza in children younger than 5 years: a 25-year prospective study. J Infect Dis. 2002;185(2):147–152.
   PubMed Web of Science ®Google Scholar
• Caini S, Huang QS, Ciblak MA, et al. Epidemiological and virological characteristics of influenza B: results of the Global Influenza B Study. Influenza Other Respir Viruses. 2015;9(Suppl 1):3–12.
   PubMedGoogle Scholar
• Wong KK, Jain S, Blanton L, et al. Influenza-associated pediatric deaths in the United States, 2004-2012. Pediatrics. 2013;132(5):796–804.
   PubMed Web of Science ®Google Scholar
• Cohen C, Moyes J, Tempia S, et al. Severe influenza-associated respiratory infection in high HIV prevalence setting, South Africa, 2009-2011. Emerg Infect Dis. 2013;19(11):1766–1774.
   PubMed Web of Science ®Google Scholar
• Lafond KE, Nair H, Rasooly MH, et al. Global role and burden of influenza in pediatric respiratory hospitalizations, 1982-2012: a systematic analysis. PLoS Med. 2016;13(3):e1001977.
   PubMed Web of Science ®Google Scholar
• Institute for Health Metrics and Evaluation. GBD results tool. (2019). Available from: http://ghdx.healthdata.org/gbd-results-tool
   Google Scholar
• Simonsen L, Spreeuwenberg P, Lustig R, et al. Global mortality estimates for the 2009 Influenza pandemic from the GLaMOR project: a modeling study. PLoS Med. 2013;10(11):e1001558.
   PubMed Web of Science ®Google Scholar
• Dawood FS, Iuliano AD, Reed C, et al. Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study. Lancet Infect Dis. 2012;12(9):687–695.
   PubMed Web of Science ®Google Scholar
• Viboud C, Simonsen L, Fuentes R, et al. Global mortality impact of the 1957-1959 influenza pandemic. J Infect Dis. 2016;213(5):738–745.
   PubMed Web of Science ®Google Scholar
• Osterholm MT, Kelley NS, Sommer A, et al. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis. 2012;12(1):36–44.
   PubMed Web of Science ®Google Scholar
• Demicheli V, Jefferson T, Di Pietrantonj C, et al. Vaccines for preventing influenza in the elderly. Cochrane Database Syst Rev. 2018;2:CD004876.
   PubMed Web of Science ®Google Scholar
• Jain VK, Rivera L, Zaman K, et al. Vaccine for prevention of mild and moderate-to-severe influenza in children. N Engl J Med. 2013;369(26):2481–2491.
   PubMed Web of Science ®Google Scholar
• Vesikari T, Knuf M, Wutzler P, et al. Oil-in-water emulsion adjuvant with influenza vaccine in young children. N Engl J Med. 2011;365(15):1406–1416.
   PubMed Web of Science ®Google Scholar
• Ashkenazi S, Vertruyen A, Aristegui J, et al. Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infections. Pediatr Infect Dis J. 2006;25(10):870–879.
   PubMed Web of Science ®Google Scholar
• Belshe RB, Edwards KM, Vesikari T, et al. Live attenuated versus inactivated influenza vaccine in infants and young children. N Engl J Med. 2007;356(7):685–696.
   PubMed Web of Science ®Google Scholar
• Fleming DM, Crovari P, Wahn U, et al. Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma. Pediatr Infect Dis J. 2006;25(10):860–869.
   PubMed Web of Science ®Google Scholar
• Jackson ML, Chung JR, Jackson LA, et al. Influenza vaccine effectiveness in the United States during the 2015-2016 season. N Engl J Med. 2017;377(6):534–543.
   PubMed Web of Science ®Google Scholar
• Poehling KA, Caspard H, Peters TR, et al. 2015-2016 vaccine effectiveness of live attenuated and inactivated influenza vaccines in children in the United States. Clin Infect Dis. 2018;66(5):665–672.
   PubMed Web of Science ®Google Scholar
• Pebody R, McMenamin J, Nohynek H. Live attenuated influenza vaccine (LAIV): recent effectiveness results from the USA and implications for LAIV programmes elsewhere. Arch Dis Child. 2018 Jan;103(1):101–105. DOI:10.1136/archdischild-2016-312165. Epub 2017 Aug 30. Review. PubMed PMID:28855230.
   Web of Science ®Google Scholar
• Ambrose CS, Bright H, Mallory R. Letter to the editor: potential causes of the decreased effectiveness of the influenza A(H1N1)pdm09 strain in live attenuated influenza vaccines. Euro Surveill. 2016;21:45.
   Google Scholar
• Grohskopf LA, Sokolow LZ, Fry AM, et al. Update: ACIP recommendations for the use of quadrivalent live attenuated influenza vaccine (LAIV4) - United States, 2018-19 influenza season. MMWR Morb Mortal Wkly Rep. 2018;67(22):643–645.
   PubMed Web of Science ®Google Scholar
• Lindsey BB, Jagne YJ, Armitage EP, et al. Effect of a Russian-backbone live-attenuated influenza vaccine with an updated pandemic H1N1 strain on shedding and immunogenicity among children in The Gambia: an open-label, observational, phase 4 study. The Lancet Respiratory Medicine. 2019. DOI:10.1016/S2213-2600(19)30086-4
   Google Scholar
• Ortiz JR, Neuzil KM, Ahonkhai VI, et al. Translating vaccine policy into action: a report from the Bill & Melinda Gates foundation consultation on the prevention of maternal and early infant influenza in resource-limited settings. Vaccine. 2012;30(50):7134–7140.
   PubMed Web of Science ®Google Scholar
• Ortiz JR, Neuzil KM. Influenza immunization of pregnant women in resource-constrained countries: an update for funding and implementation decisions. Curr Opin Infect Dis. 2017;30(5):455–462.
   PubMed Web of Science ®Google Scholar
• Tapia MD, Sow SO, Tamboura B, et al. Maternal immunisation with trivalent inactivated influenza vaccine for prevention of influenza in infants in Mali: a prospective, active-controlled, observer-blind, randomised phase 4 trial. Lancet Infect Dis. 2016;16(9):1026–1035.
   PubMed Web of Science ®Google Scholar
• Steinhoff MC, Katz J, Englund JA, et al. Year-round influenza immunisation during pregnancy in Nepal: a phase 4, randomised, placebo-controlled trial. Lancet Infect Dis. 2017 Sep;17(9):981–989. DOI:10.1016/S1473-3099(17)30252-9. Epub 2017 May 15. PubMed PMID: 28522338;PubMed Central PMCID: PMC5573632.
   PubMedGoogle Scholar
• Madhi SA, Cutland CL, Kuwanda L, et al. Influenza vaccination of pregnant women and protection of their infants. N Engl J Med. 2014;371(10):918–931.
   PubMed Web of Science ®Google Scholar
• Nunes MC, Cutland CL, Jones S, et al. Efficacy of maternal influenza vaccination against all-cause lower respiratory tract infection hospitalizations in young infants: results from a randomized controlled trial. Clin Infect Dis. 2017;65(7):1066–1071.
   PubMed Web of Science ®Google Scholar
• Steinhoff MC, Omer SB. A review of fetal and infant protection associated with antenatal influenza immunization. Am J Obstet Gynecol. 2012;207(3 Suppl):S21–27.
   PubMed Web of Science ®Google Scholar
• Fell DB, Bhutta ZA, Hutcheon JA et al. Report of the WHO technical consultation on the effect of maternal influenza and influenza vaccination on the developing fetus: montreal, Canada, september 30-october 1, 2015. Vaccine, (2017).
   Google Scholar
• Hutcheon JA, Fell DB, Jackson ML, et al. Detectable risks in studies of the fetal benefits of maternal influenza vaccination. Am J Epidemiol. 2016;184(3):227–232.
   PubMed Web of Science ®Google Scholar
• Savitz DA, Fell DB, Ortiz JR, et al. Does influenza vaccination improve pregnancy outcome? Methodological issues and research needs. Vaccine. 2015;33(47):6430–6435.
   PubMed Web of Science ®Google Scholar
• Lindsey BB, Armitage EP, Kampmann B, et al. The efficacy, effectiveness, and immunogenicity of influenza vaccines in Africa: a systematic review. Lancet Infect Dis. 2019 Apr;19(4):e110-e119. DOI:10.1016/S1473-3099(18)30490-0. Epub 2018 Dec 12.
   PubMed Web of Science ®Google Scholar
• Diallo A, Diop OM, Diop D, et al. Effectiveness of seasonal influenza vaccination of children in Senegal during a year of vaccine mismatch: a cluster-randomized trial. Clin Infect Dis. 2019 Jan 28. DOI:10.1093/cid/ciz066. [Epub ahead of print] PubMed PMID: 30689757.
   Google Scholar
• Sullender W, Fowler K, Krishnan A, et al. Design and initiation of a study to assess the direct and indirect effects of influenza vaccine given to children in rural India. Vaccine. 2012;30(35):5235–5239.
   PubMed Web of Science ®Google Scholar
• Brooks WA, Zaman K, Lewis KD, et al. Efficacy of a Russian-backbone live attenuated influenza vaccine among young children in Bangladesh: a randomised, double-blind, placebo-controlled trial. Lancet Glob Health. 2016;4(12):e946–e954.
   PubMed Web of Science ®Google Scholar
• Victor JC, Lewis KD, Diallo A, et al. Efficacy of a Russian-backbone live attenuated influenza vaccine among children in Senegal: a randomised, double-blind, placebo-controlled trial. Lancet Glob Health. 2016;4(12):e955–e965.
   PubMed Web of Science ®Google Scholar
• Brickley EB, Wright PF, Khalenkov A, et al. The effect of pre-existing immunity on virus detection and immune responses in a phase II randomized trial of a Russian-backbone live attenuated influenza vaccine in Bangladeshi children. Clin Infect Dis. 2018. Nov 27. DOI:10.1093/cid/ciy1004 [Epub ahead of print]. PubMed PMID: 30481269.
   PubMed Web of Science ®Google Scholar
• Lewis KDC, Ortiz JR, Rahman MZ, et al. Immunogenicity and viral shedding of Russian-backbone seasonal trivalent, live-attenuated influenza vaccine in a phase II randomized placebo-controlled trial among pre-school aged children in urban Bangladesh. Clin Infect Dis. 2018. Nov 27. DOI:10.1093/cid/ciy1003 [Epub ahead of print] PubMed PMID: 30481272.
   Google Scholar
• Ortiz JR, Goswami D, Lewis KD, et al. Safety of Russian-backbone seasonal trivalent, live-attenuated influenza vaccine in a phase II randomized placebo-controlled clinical trial among children in urban Bangladesh. Vaccine. 2015;33(29):3415–3421.
   PubMed Web of Science ®Google Scholar
• Belshe RB. The potential of LAIV for the prevention of influenza in children. Clin Infect Dis. 2018. Nov 27. doi: 10.1093/cid/ciy1007 [Epub ahead of print]. PubMed PMID: 30517601.
   PubMedGoogle Scholar
• World Health Organization. Information sheet observed rate of vaccine reactions influenza vaccine. (2012). Available from: https://www.who.int/vaccine_safety/initiative/tools/Influenza_Vaccine_rates_information_sheet.pdf
   Google Scholar
• Halasa NB, Gerber MA, Berry AA, et al. Safety and immunogenicity of full-dose Trivalent Inactivated Influenza Vaccine (TIV) compared with half-dose TIV administered to children 6 through 35 months of age. J Pediatric Infect Dis Soc. 2015;4(3):214–224.
   PubMed Web of Science ®Google Scholar
• Food and Drug Administration. Summary basis for regulatory action. (2018). Available from: https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM623103.pdf
   Google Scholar
• D’Angiolella LS, Lafranconi A, Cortesi PA, et al. Costs and effectiveness of influenza vaccination: a systematic review. Ann Ist Super Sanita. 2018;54(1):49–57.
   PubMed Web of Science ®Google Scholar
• de Francisco Shapovalova N, Donadel M, Jit M, et al. A systematic review of the social and economic burden of influenza in low- and middle-income countries. Vaccine. 2015;33(48):6537–6544.
   PubMed Web of Science ®Google Scholar
• Pecenka C, Munthali S, Chunga P, et al. Maternal influenza immunization in Malawi: piloting a maternal influenza immunization program costing tool by examining a prospective program. PloS One. 2017;12(12):e0190006.
   PubMed Web of Science ®Google Scholar
• Pan American Health Organization. Expanded program of immunization vaccine prices for year 2019. (2019). Available from: https://www.paho.org/hq/index.php?option=com_docman&view=download&category_slug=revolving-fund-2625&alias=25038-revolving-fund-vaccine-prices-038&Itemid=270&lang=en
   Google Scholar
• McLean KA, Goldin S, Nannei C, et al. 2015 global production capacity of seasonal and pandemic influenza vaccine. Vaccine. 2016;34(45):5410–5413.
   PubMed Web of Science ®Google Scholar
• Debellut F, Hendrix N, Ortiz JR, et al. Forecasting demand for maternal influenza immunization in low- and lower-middle-income countries. PLoS One. 2018;13(6):e0199470.
   PubMed Web of Science ®Google Scholar
• Ferdinands JM, Olsho LE, Agan AA, et al. Effectiveness of influenza vaccine against life-threatening RT-PCR-confirmed influenza illness in US children, 2010-2012. J Infect Dis. 2014;210(5):674–683.
   PubMed Web of Science ®Google Scholar
• DP R, CB B, Shetterly S, et al. Effectiveness of the 2003-2004 influenza vaccine among children 6 months to 8 years of age, with 1 vs 2 doses. Pediatrics. 2005;116(1):153–159.
   PubMed Web of Science ®Google Scholar
• Halasa NB, Gerber MA, Chen Q, et al. Safety and immunogenicity of trivalent inactivated influenza vaccine in infants. J Infect Dis. 2008;197(10):1448–1454.
   PubMed Web of Science ®Google Scholar
• Walter EB, Englund JA, Blatter M, et al. Trivalent inactivated influenza virus vaccine given to two-month-old children: an off-season pilot study. Pediatr Infect Dis J. 2009;28(12):1099–1104.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Meeting to assess live-attenuated influenza vaccines to prevent paediatric influenza disease in low and middle income countries: executive summary. (2014). Available from: https://www.who.int/influenza_vaccines_plan/Executive_Summary_LAIV_meeting_FINAL.pdf
   Google Scholar
• Oshansky CM, Zhou J, Gao Y, et al. Safety and immunogenicity of influenza A(H5N1) vaccine stored up to twelve years in the National Pre-Pandemic Influenza Vaccine Stockpile (NPIVS). Vaccine. 2019;37(3):435–443.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Data, statistics and graphics. (2019). Available from: https://www.who.int/immunization/monitoring_surveillance/data/en/
   Google Scholar
• Report from Gavi, the vaccine alliance meeting of the strategic advisory group of experts on immunisation (SAGE). 2019. Available from: https://www.who.int/immunization/sage/meetings/2019/april/1_SAGE_April_2019_GAVI_Berkeley.pdf?ua=1
   Google Scholar
• World Health Organization. Global vaccine action plan 2011-2020. (2013). Available from: https://www.who.int/immunization/global_vaccine_action_plan/GVAP_doc_2011_2020/en/
   Google Scholar
• World Health Organization. Highlights from the meeting of the Strategic Advisory Group of Experts (SAGE) on immunization. 2019. Available from: https://www.who.int/immunization/sage/meetings/2019/april/SAGE_April_2019_meeting_summary.pdf?ua=1
   Google Scholar
• United Nations Development Programme. Sustainable development goals. (2019). Available from: https://sustainabledevelopment.un.org/
   Google Scholar
• World Health O. Typhoid vaccines: WHO position paper, march 2018 - recommendations. Vaccine. 2019;37(2):214–216.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Q&A on the phase 3 trial results for malaria vaccine RTS,S/AS01. (2017). Available from: https://www.who.int/malaria/media/rtss-phase-3-trial-qa/en/
   Google Scholar
• Erbelding EJ, Post D, Stemmy E, et al. A universal influenza vaccine: the strategic plan for the national institute of allergy and infectious diseases. J Infect Dis. 2018.
   PubMed Web of Science ®Google Scholar
• Ortiz JR, Hickling J, Jones R, et al. Report on eighth WHO meeting on development of influenza vaccines that induce broadly protective and long-lasting immune responses: chicago, USA, 23-24 august 2016. Vaccine. 2018;36(7):932–938.
   PubMed Web of Science ®Google Scholar
• Cox NJ, Hickling J, Jones R, et al. Report on the second WHO integrated meeting on development and clinical trials of influenza vaccines that induce broadly protective and long-lasting immune responses: geneva, Switzerland, 5–7 may 2014. Vaccine. 2015;33(48):6503–6510.
   PubMed Web of Science ®Google Scholar
• World Health Organization.WHO preferred product characteristics for next-generation influenza vaccines. (2017). Available from: https://apps.who.int/iris/bitstream/handle/10665/258767/9789241512466-eng.pdf
   Google Scholar
• Gavi, the Vaccine Alliance. Gavi alliance board review of decisions - 28-29 november 2018 (2018). Available from: https://www.gavi.org/about/governance/gavi-board/decisions/2018/gavi-alliance-board-review-of-decisions—28-29-november-2018/
   Google Scholar